Easing financial prescription burden

I welcome that Boots have finally decided to follow my lead in taking the required steps to ease the financial burden on the prescription paying public in these difficult times.

It is unfortunate that it has taken them nearly three years to catch up with me in implementing cost-saving changes and have only reluctantly done so after they, along with other major pharmacy chains, were exposed late last year as charging the highest prices for prescriptions medicines (Irish Independent, Oct & Nov 2011).

I wonder what has brought about this ‘Road to Damascus’-like conversion by Boots from being one of the most expensive providers of prescription medicines to now being the champion for value and transparency in their prescription pricing structure.